Life Sciences

ISPOR 2018 was speaking our language

Share this post:

ISPOR Booth

We’re all patients,” noted Dr. Michelle McMurry-Heath, a panelist in the first plenary session that kicked off ISPOR 2018, a 5-day conference devoted to health economics and outcomes research (HEOR) in Baltimore at the end of May. In saying so, the Vice President of Regulatory Affairs for Johnson & Johnson voiced the immediacy of the research that was highlighted in this year’s presentations, health research that affects every one of us.

“Patients,” she went on to say, “are making decisions and preferences every day.” One of her co-panelists agreed that “most people’s lives happen outside of the hospital, outside of the doctor’s office.” And in a spotlight session that followed, Dr. Harlan Krumholz of Yale University stressed that “medicine is now an information science and will be unrecognizable in 10 years.”

This feeling was echoed throughout ISPOR where many sessions were devoted to areas in digital health and AI and trends exceptionally aligned with offerings from IBM Watson Health:

accelerating drug approvals
• decreasing drug spending
• delivering innovative and curative therapies
• serving an aging population
• developing preventive medicine

As speaker Dr. Adrian Hernandez from Duke University aptly concluded, “To lock up the data is to lock up the answers.” At Watson Health, we’re all about revealing answers, and we’re eager to share how our solutions in the life sciences are enabling streamlined approaches to both discovery and speed-to-market.

More Life Sciences stories

Watson Health: Setting the Record Straight

Written by Dr. John E. Kelly III | AI, Blog Post, Oncology & Genomics

We at IBM have a lot to be proud of, including our pioneering work with Watson Health. Unfortunately, some media reports, including an August 11th story published by The Wall Street Journal, distort and ignore facts when suggesting IBM has not made “enough” progress on bringing the benefits of AI to healthcare. ...read more


Watson Health is committed to using AI to tackle major healthcare challenges

Written by Deborah DiSanzo | AI, Blog Post, Oncology & Genomics

I would like to provide an update on Watson Health and address a few misperceptions. If you only read certain media reports recently, you would have an incomplete and inaccurate perspective, especially as it relates to our Watson for Oncology product. ...read more


“Connected health” designed for health

Written by Watson Health | Blog Post, Cognitive Computing, Life Sciences

Over the years, the life sciences industry has been investing in capturing and analyzing patient health information. Specifically, companies have been creating digital health applications with the goal of improving treatment and care. ...read more